The less invasive method could help men avoid some of the unpleasant side effects such as urinary incontinence and sexual dysfunction, which are known deterrents for patients facing potential prostatectomy.

New findings indicate as many as 96% of men with positive PSA labs who show insignificant or slow-growing cancer on MRI can safely forego biopsy for three or more years. 

A recent comparison of the two modalities’ utility for guiding radiation therapy for prostate cancer shows numerous benefits for MRI over CT.

Given the complex nature of intrahepatic cholangiocarcinoma, efforts to develop more effective methods of treating it have increased over the years.

More detailed estimations of lesion size could give providers greater insight into how to best manage a patient’s treatment plan. 

“No one wants to get surgery if they can avoid it. Now we have a powerful tool to help patients and their doctors predict who would benefit from surgery after initial chemotherapy and radiation."

The heightened sensitivity of MRI is beneficial in that it allows for earlier detection of cancers, but it also presents challenges for providers tasked with managing patients’ care plans.

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.